behavior/neurological
• no significant increase in wakefulness is seen in homozygotes after injection of 15 mg/kg, 10 mg/kg, or 5 mg/kg caffeine, unlike wild-type mice
(J:99612)
• however, baseline circadian sleep-wake profiles are identical to wild-type
(J:99612)
• single exposure amphetamine or cocaine stimulated increases in locomotor activity are reduced compared to wild-type mice
(J:107988)
• however, amphetamine stimulated increases in fine movement are not significantly different from wild-type
(J:107988)
|
• reduced spontaneous activity most prominently in the dark cycle; however normal locomotor circadian rhythms are seen
(J:107988)
|
homeostasis/metabolism
• 24 hours after middle cerebral arterial occlusion neurological deficit scores for homozygotes are reduced by 50-60% compared to wild-type mice
|
• after middle cerebral arterial occlusion total infarct volume is reduced by 26% using hematoxylin and eosin staining or by 77% using TTC staining (marker of intact cellular metabolism) compared to wild-type mice
|
nervous system
N |
• morphology of cortex and striatum appears normal
(J:73594)
• dopaminergic innervation is normal
(J:107988)
|
• 24 hours after middle cerebral arterial occlusion neurological deficit scores for homozygotes are reduced by 50-60% compared to wild-type mice
|
• after middle cerebral arterial occlusion total infarct volume is reduced by 26% using hematoxylin and eosin staining or by 77% using TTC staining (marker of intact cellular metabolism) compared to wild-type mice
|
cardiovascular system
N |
• basal mean arterial blood pressure, absolute blood flow, and cortical cerebral blood flow before, during. and after middle cerebral arterial occlusion is similar to wild-type mice
|
vision/eye
N |
• normal growth in the anterior segment and normal pupil size
|
• sclera contains denser collagen fibrils with reduced diameter
|
• mice develop greater myopia than wild-type mice, that is associated with increases in vitreous chamber depth and axial length from P28 to P56
|
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
myopia | DOID:11830 |
OMIM:160700 OMIM:255500 OMIM:300613 OMIM:310460 OMIM:603221 OMIM:608367 OMIM:608474 OMIM:608908 OMIM:609256 OMIM:609257 OMIM:609258 OMIM:609259 OMIM:609994 OMIM:609995 OMIM:610320 OMIM:612554 OMIM:612717 OMIM:613959 OMIM:613969 OMIM:614166 OMIM:614167 OMIM:615420 OMIM:615431 OMIM:615946 |
J:164077 |